The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism - PubMed (original) (raw)
Review
doi: 10.5551/jat.13.21.
Affiliations
- PMID: 16505588
- DOI: 10.5551/jat.13.21
Free article
Review
The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism
Kikuo Isoda et al. J Atheroscler Thromb. 2006 Feb.
Free article
Abstract
This review summarizes both the structure and function of IL-1 receptor antagonist (IL-1Ra), and relates our new findings, particularly those obtained in IL-1Ra-deficient mice (IL-1Ra(-/-)), to the role of IL-1Ra in arterial diseases and cholesterol metabolism. IL-1Ra(-/-) mice show an increase in neointima-formation after arterial injury. Heterozygosity in the IL-1Ra gene against the apolipoprotein E-deficient background revealed a role for IL-1 in promoting atherogenic cell signaling and that the larger lesions of IL-1Ra(-/-) mice are enriched in macrophages and depleted of smooth muscle cells. Furthermore, IL-1Ra(-/-) mice developed severe fatty livers and hypercholesteroremia following 20 weeks on a atherogenic diet compared to WT mice. Taken together, these results suggest that IL-1Ra plays important roles in restenosis after angioplasty, the development of atherosclerosis, and the metabolism of cholesterol in vivo.
Similar articles
- Interleukin-1 receptor antagonist originating from bone marrowderived cells and non-bone marrow-derived cells helps to suppress arterial inflammation and reduce neointimal formation after injury.
Isoda K, Akita K, Isobe S, Niida T, Adachi T, Iwakura Y, Daida H. Isoda K, et al. J Atheroscler Thromb. 2014;21(11):1208-18. doi: 10.5551/jat.25668. Epub 2014 Sep 16. J Atheroscler Thromb. 2014. PMID: 25223697 - Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury.
Isoda K, Shiigai M, Ishigami N, Matsuki T, Horai R, Nishikawa K, Kusuhara M, Nishida Y, Iwakura Y, Ohsuzu F. Isoda K, et al. Circulation. 2003 Aug 5;108(5):516-8. doi: 10.1161/01.CIR.0000085567.18648.21. Epub 2003 Jul 21. Circulation. 2003. PMID: 12874179 - [NASH model-- role of interleukin-1 receptor].
Sawada S, Saito H, Kusuhara M. Sawada S, et al. Nihon Rinsho. 2006 Jun;64(6):1063-70. Nihon Rinsho. 2006. PMID: 16768110 Review. Japanese. - The interleukin-1 receptor antagonist and its delivery by gene transfer.
Evans CH, Robbins PD. Evans CH, et al. Receptor. 1994 Spring;4(1):9-15. Receptor. 1994. PMID: 8038709 Review.
Cited by
- The Complex Interplay of Inflammation, Metabolism, Epigenetics, and Sex in Calcific Disease of the Aortic Valve.
Ferrari S, Pesce M. Ferrari S, et al. Front Cardiovasc Med. 2022 Jan 6;8:791646. doi: 10.3389/fcvm.2021.791646. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35071359 Free PMC article. Review. - Mitogen and Stress-Activated Kinases 1 and 2 Mediate Endothelial Dysfunction.
Akbar N, Forteath C, Hussain MS, Reyskens K, Belch JJF, Lang CC, Mordi IR, Bhalraam U, Arthur JSC, Khan F. Akbar N, et al. Int J Mol Sci. 2021 Aug 11;22(16):8655. doi: 10.3390/ijms22168655. Int J Mol Sci. 2021. PMID: 34445361 Free PMC article. - Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation.
Kostadinova L, Shive CL, Anthony DD. Kostadinova L, et al. Cancers (Basel). 2019 Nov 25;11(12):1867. doi: 10.3390/cancers11121867. Cancers (Basel). 2019. PMID: 31769428 Free PMC article. Review. - Examining the Role of and Treatment Directed at IL-1β in Atherosclerosis.
Khan R, Rheaume E, Tardif JC. Khan R, et al. Curr Atheroscler Rep. 2018 Sep 15;20(11):53. doi: 10.1007/s11883-018-0754-6. Curr Atheroscler Rep. 2018. PMID: 30219977 Review. - Association between IL-1β + 3954C/T polymorphism and myocardial infarction risk: A meta-analysis.
Fang Y, Xie H, Lin Z. Fang Y, et al. Medicine (Baltimore). 2018 Jul;97(30):e11645. doi: 10.1097/MD.0000000000011645. Medicine (Baltimore). 2018. PMID: 30045312 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical